
Junyi Li
Articles
-
3 weeks ago |
tandfonline.com | Colby Parkinson |Junyi Li |Tingting Liu |Bing Pan
About Your PrivacyWe process your data to deliver content or advertisements and measure the delivery of such content or advertisements to extract insights about our website. We share this information with our partners on the basis of consent and legitimate interest. You may exercise your right to consent or object to a legitimate interest, based on a specific purpose below or at a partner level in the link under each purpose.
-
Apr 28, 2024 |
mdpi.com | Junyi Li |Min Lin |Zexin Xie |Liwenyu Chen
All articles published by MDPI are made immediately available worldwide under an open access license. No specialpermission is required to reuse all or part of the article published by MDPI, including figures and tables. Forarticles published under an open access Creative Common CC BY license, any part of the article may be reused withoutpermission provided that the original article is clearly cited. For more information, please refer tohttps://www.mdpi.com/openaccess.
-
Feb 11, 2024 |
mdpi.com | Junyi Li |Jian Yang |Yun Xia |Junyi Wang
All articles published by MDPI are made immediately available worldwide under an open access license. No specialpermission is required to reuse all or part of the article published by MDPI, including figures and tables. Forarticles published under an open access Creative Common CC BY license, any part of the article may be reused withoutpermission provided that the original article is clearly cited. For more information, please refer tohttps://www.mdpi.com/openaccess.
-
Jan 11, 2024 |
pubs.rsc.org | Junyi Li |Fei Peng |Hui Huang |Xiaoyan Xu
Characterization, mechanism and in vivo validation of Helicobacter pylori antagonism by probiotics screened from infants’ feces and oral cavity† Helicobacter pylori (H. pylori) infection is a major cause of chronic gastritis, intestinal metaplasia, and gastric carcinoma. Antibiotics, the conventional regimen for eliminating H. pylori, cause severe bacterial resistance, gut dysbiosis and hepatic insufficiency.
-
Dec 20, 2023 |
pubs.rsc.org | Junyi Li |Fei Peng |Hui Huang |Xiaoyan Xu
Characterization, Mechanism and in vivo Validation of Helicobacter pylori Antagonism by Probiotics Screened from Infants' Feces and Oral Cavity Helicobacter pylori (H. pylori) infection is a major cause of chronic gastritis, intestinal metaplasia, and gastric carcinoma. Antibiotics, the conventional regimen for eliminating H. pylori, cause severe bacterial resistance, gut dysbiosis and hepatic insufficiency.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →